EW in the 13F filings
Edwards Lifesciences Corp · CUSIP 28176E108
- Quarter end
- 31 Mar 2025
- the date the book describes
- Filed
- 21 Jul 2025
- latest of these filings; the earliest 7 May 2025
- Managers listing it
- 23
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q4 2024 and Q1 2025; 18 listed it in both
- Shares listed
- 69,542,218
- combined, among listed positions
- Reported value
- $5.0bn
- combined, at the quarter end
Among the 95 comparable managers: 14 buyers (opened or added shares) and 11 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing EW in Q1 2025
23 of 23 holders
Largest increases and reductions, by shares
Increases
- Citadel Advisors LLCexisting position · 13,381,683 shares now+3,963,609
- Holocene Advisors LPexisting position · 3,480,517 shares now+1,070,432
- Point72 Asset Management LPexisting position · 1,468,733 shares now+880,527
- Balyasny Asset Management LLCexisting position · 2,124,433 shares now+729,255
- Man Group PLCexisting position · 951,227 shares now+391,777
Reductions
- Wellington Management Group LLPexisting position · 29,134,790 shares now-4,076,089
- Marshall Wace LLPexisting position · 3,030,671 shares now-2,782,748
- AllianceBernstein LPexisting position · 1,156,854 shares now-881,823
- Janus Henderson Group Ltdexisting position · 1,002,501 shares now-159,043
- Baillie Gifford & Coexisting position · 581,441 shares now-125,355
New positions and exits
New (1)
Exited (2)
- Soros Fund Management LLCwas $19m
- Farallon Capital Management LLCwas $222k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 6 | $2.5bn | n.a. | n.a. |
| Q3 2013 | 14 | $2.3bn | n.a. | n.a. |
| Q4 2013 | 8 | $2.4bn | n.a. | n.a. |
| Q1 2014 | 10 | $2.9bn | n.a. | n.a. |
| Q2 2014 | 7 | $3.0bn | n.a. | n.a. |
| Q3 2014 | 13 | $2.9bn | n.a. | n.a. |
| Q4 2014 | 18 | $3.4bn | n.a. | n.a. |
| Q1 2015 | 18 | $3.1bn | n.a. | n.a. |
| Q2 2015 | 15 | $2.3bn | n.a. | n.a. |
| Q3 2015 | 16 | $2.8bn | n.a. | n.a. |
| Q4 2015 | 19 | $2.7bn | n.a. | n.a. |
| Q1 2016 | 20 | $2.7bn | n.a. | n.a. |
| Q2 2016 | 26 | $3.1bn | n.a. | n.a. |
| Q3 2016 | 21 | $3.8bn | n.a. | n.a. |
| Q4 2016 | 18 | $2.8bn | n.a. | n.a. |
| Q1 2017 | 23 | $2.0bn | n.a. | n.a. |
| Q2 2017 | 21 | $2.8bn | n.a. | n.a. |
| Q3 2017 | 24 | $2.7bn | n.a. | n.a. |
| Q4 2017 | 25 | $2.8bn | n.a. | n.a. |
| Q1 2018 | 23 | $3.7bn | n.a. | n.a. |
| Q2 2018 | 23 | $4.1bn | n.a. | n.a. |
| Q3 2018 | 17 | $5.2bn | n.a. | n.a. |
| Q4 2018 | 21 | $5.0bn | n.a. | n.a. |
| Q1 2019 | 23 | $6.1bn | n.a. | n.a. |
| Q2 2019 | 23 | $5.7bn | n.a. | n.a. |
| Q3 2019 | 24 | $6.7bn | n.a. | n.a. |
| Q4 2019 | 28 | $7.2bn | n.a. | n.a. |
| Q1 2020 | 29 | $5.8bn | n.a. | n.a. |
| Q2 2020 | 30 | $5.9bn | n.a. | n.a. |
| Q3 2020 | 21 | $6.1bn | n.a. | n.a. |
| Q4 2020 | 14 | $6.3bn | n.a. | n.a. |
| Q1 2021 | 22 | $6.0bn | n.a. | n.a. |
| Q2 2021 | 25 | $7.7bn | n.a. | n.a. |
| Q3 2021 | 22 | $8.5bn | n.a. | n.a. |
| Q4 2021 | 20 | $9.2bn | n.a. | n.a. |
| Q1 2022 | 22 | $7.9bn | n.a. | n.a. |
| Q2 2022 | 22 | $6.6bn | n.a. | n.a. |
| Q3 2022 | 29 | $6.2bn | n.a. | n.a. |
| Q4 2022 | 28 | $5.8bn | n.a. | n.a. |
| Q1 2023 | 26 | $5.8bn | n.a. | n.a. |
| Q2 2023 | 25 | $5.9bn | n.a. | n.a. |
| Q3 2023 | 25 | $4.6bn | n.a. | n.a. |
| Q4 2023 | 22 | $5.1bn | 10 | 12 |
| Q1 2024 | 23 | $7.0bn | 14 | 13 |
| Q2 2024 | 20 | $6.8bn | 12 | 11 |
| Q3 2024 | 19 | $3.8bn | 11 | 9 |
| Q4 2024 | 22 | $5.0bn | 12 | 11 |
| Q1 2025 | 23 | $5.0bn | 14 | 11 |
| Q2 2025 | 23 | $5.2bn | 17 | 7 |
| Q3 2025 | 22 | $5.0bn | 9 | 15 |
| Q4 2025 | 23 | $5.9bn | 22 | 14 |
| Q1 2026 | 25 | $6.0bn | 15 | 21 |
| Q2 2026 | 25 | $6.9bn | 18 | 17 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
EW and LLY →EW and JNJ →EW and VRTX →Choose a stock to compare with EW →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own EW, latest filings →Back to the 13F Explorer →